Skip to main content
Top
Published in: Journal of General Internal Medicine 1/2021

01-01-2021 | SARS-CoV-2 | Original Research

Derivation and Internal Validation of a Model to Predict the Probability of Severe Acute Respiratory Syndrome Coronavirus-2 Infection in Community People

Authors: Carl van Walraven, MD MSc, Douglas G. Manuel, MD MSc, Marc Desjardins, PhD, Alan J. Forster, MD MSc

Published in: Journal of General Internal Medicine | Issue 1/2021

Login to get access

Abstract

Background

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19 disease. There are concerns regarding limited testing capacity and the exclusion of cases from unproven screening criteria. Knowing COVID-19 risks can inform testing. This study derived and assessed a model to predict risk of SARS-CoV-2 in community-based people.

Methods

All people presenting to a community-based COVID-19 screening center answered questions regarding symptoms, possible exposure, travel, and occupation. These data were anonymously linked to SARS-CoV-2 testing results. Logistic regression was used to derive a model to predict SARS-CoV-2 infection. Bootstrap sampling evaluated the model.

Results

A total of 9172 consecutive people were studied. Overall infection rate was 6.2% but this varied during the study period. SARS-CoV-2 infection likelihood was primarily influenced by contact with a COVID-19 case, fever symptoms, and recent case detection rates. Internal validation found that the SARS-CoV-2 Risk Prediction Score (SCRiPS) performed well with good discrimination (c-statistic 0.736, 95%CI 0.715–0.757) and very good calibration (integrated calibration index 0.0083, 95%CI 0.0048–0.0131). Focusing testing on people whose expected SARS-CoV-2 risk equaled or exceeded the recent case detection rate would increase the number of identified SARS-CoV-2 cases by 63.1% (95%CI 54.5–72.3).

Conclusion

The SCRiPS model accurately estimates the risk of SARS-CoV-2 infection in community-based people undergoing testing. Using SCRiPS can importantly increase SARS-CoV-2 infection identification when testing capacity is limited.
Appendix
Available only for authorised users
Literature
1.
go back to reference WHO = World Health Organization; WHO reference number: WHO/2019-nCoV/lab_testing/2020.1. 2020 WHO = World Health Organization; WHO reference number: WHO/2019-nCoV/lab_testing/2020.1. 2020
2.
go back to reference Day M. Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village. BMJ (Clinical research ed) ) 2020;368:m1165. Day M. Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village. BMJ (Clinical research ed) ) 2020;368:m1165.
3.
go back to reference Fineberg HV. Ten Weeks to Crush the Curve. N Engl J Med 2020;NEJMe2007263. Fineberg HV. Ten Weeks to Crush the Curve. N Engl J Med 2020;NEJMe2007263.
6.
go back to reference Sun Y, Koh V, Marimuthu K et al. Epidemiological and Clinical Predictors of COVID-19. Clinical Infectious Diseases 2020;1-31. Sun Y, Koh V, Marimuthu K et al. Epidemiological and Clinical Predictors of COVID-19. Clinical Infectious Diseases 2020;1-31.
8.
go back to reference Menni C, Valdes AM, Freidin MB et al. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nature Medicine 2020; 26: 1037–1040.CrossRef Menni C, Valdes AM, Freidin MB et al. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nature Medicine 2020; 26: 1037–1040.CrossRef
9.
go back to reference Weiskopf D, Weinberger B, Grubeck-Loebenstein B. The aging of the immune system. Transplant International 2009;22(11):1041-1050.CrossRef Weiskopf D, Weinberger B, Grubeck-Loebenstein B. The aging of the immune system. Transplant International 2009;22(11):1041-1050.CrossRef
10.
go back to reference Steyerberg EW. Overfitting and optimism in prediction models. Clinical Prediction Models. 2 ed. New York: Springer; 2019:95-112.CrossRef Steyerberg EW. Overfitting and optimism in prediction models. Clinical Prediction Models. 2 ed. New York: Springer; 2019:95-112.CrossRef
11.
go back to reference Harrell FE. General aspects of fitting regression models. Regression Modelling Strategies. 2 ed. New York: Springer; 2015:13-42. Harrell FE. General aspects of fitting regression models. Regression Modelling Strategies. 2 ed. New York: Springer; 2015:13-42.
12.
go back to reference Austin PC, Steyerberg EW. Graphical assessment of internal and external calibration of logistic regression models by using loess smoothers. Stat Med 2014;33(3):517-535.CrossRef Austin PC, Steyerberg EW. Graphical assessment of internal and external calibration of logistic regression models by using loess smoothers. Stat Med 2014;33(3):517-535.CrossRef
13.
go back to reference Steyerberg EW. Evaluation of Clinical Usefulness. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. Second ed. Leiden, The Netherlands: Springer; 2019:309-328.CrossRef Steyerberg EW. Evaluation of Clinical Usefulness. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. Second ed. Leiden, The Netherlands: Springer; 2019:309-328.CrossRef
14.
go back to reference Efron B, Tibshirani RJ. Confidence intervals based on bootstrap percentiles. An introduction to the bootstrap. New York: Chapman&Hall; 1994:168-177. Efron B, Tibshirani RJ. Confidence intervals based on bootstrap percentiles. An introduction to the bootstrap. New York: Chapman&Hall; 1994:168-177.
15.
go back to reference Moons KGM, Altman DG, Reitsma JB et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration. Ann Intern Med 2015;162(1):W1-W73.CrossRef Moons KGM, Altman DG, Reitsma JB et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration. Ann Intern Med 2015;162(1):W1-W73.CrossRef
16.
go back to reference Wolff RF, Moons KGM, Riley RD et al. PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies. Ann Intern Med 2019;170(1):51-58.CrossRef Wolff RF, Moons KGM, Riley RD et al. PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies. Ann Intern Med 2019;170(1):51-58.CrossRef
Metadata
Title
Derivation and Internal Validation of a Model to Predict the Probability of Severe Acute Respiratory Syndrome Coronavirus-2 Infection in Community People
Authors
Carl van Walraven, MD MSc
Douglas G. Manuel, MD MSc
Marc Desjardins, PhD
Alan J. Forster, MD MSc
Publication date
01-01-2021
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 1/2021
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-06307-x

Other articles of this Issue 1/2021

Journal of General Internal Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.